This is of particular importance, because the same E2 and P administration failed to lower LH in PCOS women with no flutamide treatment [58], suggesting that hyperandrogenemia contributes to impaired steroid (E2 or P) hormone feedback in PCOS. The gene discussed is PLOD1; the disease is polycystic ovary syndrome.